RADIOSARP
Phase 1 Completed
41 enrolled 15 charts
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma
Phase 1 Completed
9 enrolled 10 charts
First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma
Phase 1 Completed
21 enrolled
TRAMUNE
Phase 1 Completed
40 enrolled 23 charts
Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours
Phase 1 Completed
32 enrolled
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
Phase 1 Completed
32 enrolled
Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma
Phase 1 Completed
8 enrolled
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
Phase 1 Completed
27 enrolled 7 charts
A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
Phase 1 Completed
56 enrolled
Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
Phase 1 Completed
90 enrolled
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
Phase 1 Completed
25 enrolled
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels
Phase 1 Completed
42 enrolled 39 charts
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Phase 1 Completed
184 enrolled 20 charts
Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
Phase 1 Completed
24 enrolled
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
Phase 1 Completed
41 enrolled
DUET-3
Phase 1 Completed
198 enrolled
Dendritic Cell Vaccine for Children and Adults With Sarcoma
Phase 1 Completed
19 enrolled
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Phase 1 Completed
22 enrolled
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
Phase 1 Completed
15 enrolled
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma
Phase 1 Completed
54 enrolled 28 charts
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Phase 1 Completed
117 enrolled
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Phase 1 Completed
282 enrolled
A Study of PRT2527 in Participants With Advanced Solid Tumors
Phase 1 Completed
30 enrolled
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Phase 1 Completed
24 enrolled
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Phase 1 Completed
71 enrolled
Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
Phase 1 Completed
7 enrolled
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
Phase 1 Completed
16 enrolled
Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma
Phase 1 Completed
36 enrolled
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers
Phase 1 Completed
38 enrolled
Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
Phase 1 Completed
7 enrolled
A Study of PRT1419 in Patients With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
Phase 1 Completed
14 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Phase 1 Completed
17 enrolled 14 charts
Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis
Phase 1 Completed
11 enrolled
Pazopanib and ARQ 197 for Advanced Solid Tumors
Phase 1 Completed
32 enrolled 21 charts
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Phase 1 Completed
30 enrolled
L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours
Phase 1 Completed
29 enrolled
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
Phase 1 Completed
147 enrolled 34 charts
Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas
Phase 1 Completed
25 enrolled
NY-ESO-1
Phase 1 Completed
50 enrolled 17 charts
TOMAS
Phase 1 Completed
50 enrolled
PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma
Phase 1 Completed
16 enrolled
A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Phase 1 Completed
24 enrolled 21 charts
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Phase 1 Completed
89 enrolled
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Phase 1 Completed
11 enrolled
AflacST1402
Phase 1 Completed
13 enrolled
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
Phase 1 Completed
21 enrolled
To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Phase 1 Completed
22 enrolled